利拉鲁肽治疗肥胖2型糖尿病并发阻塞性睡眠呼吸暂停综合征的效果(1)
摘要 目的:探讨利拉鲁肽治疗肥胖2型糖尿病并发OSAHS的应用效果。方法:选取2017年7月至2018年7月厦门市第三医院收治的肥胖2型糖尿病并OSAHS患者78例作为研究对象,按照治疗方案不同分为对照组和观察组,每组39例。对照组给予常规治疗,观察组在此基础上给予利拉鲁肽治疗。比较分析治疗效果。结果:观察组治疗效果优于对照组,差异有统计学意义(P<0.05);治疗后,观察组FBG、HOMA-IR、MBI均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组AHI低于对照组,LSPO2高于对照组,差异有统计学意义(P<0.05);结论:对肥胖2型糖尿病并OSAHS患者给予利拉鲁肽治疗,有效改善了患者的血糖水平、通气功能,临床治疗效果显著。关键词 利拉鲁肽;肥胖2型糖尿病;阻塞性睡眠呼吸暂停综合征;血糖水平;通气功能
Abstract Objective:To investigate the effect of liraglutide in the treatment of obese type 2 diabetes mellitus complicated with obstructive sleep apnea syndrome(OSAHS).Methods:78 obese patients with type 2 diabetes mellitus and OSAHS who were treated from July 2017 to July 2018 were enrolled and divided into control group and observation group according to different treatment schemes ......
您现在查看是摘要页,全文长 3327 字符。